Menu

News Releases

Date Title  
Toggle Summary Summit Healthcare selects 2bPrecise for Pharmacogenomics
Arizona-based provider launches precision medicine initiative for improved outcomes and patient experience CHICAGO and PITTSBURGH and SHOW LOW, Ariz., Jan. 28, 2019 (GLOBE NEWSWIRE) -- Allscripts Healthcare Solutions, Inc. (NASDAQ: MDRX) announced today that Summit Healthcare will implement the
Toggle Summary Allscripts offers free pharmacogenomics testing to U.S.-based associates
Program will help individuals understand the efficacy and safety of specific medications CHICAGO , Jan. 22, 2019 (GLOBE NEWSWIRE) -- Allscripts Healthcare Solutions (NASDAQ: MDRX) today launched a precision medicine program to benefit its U.S.-based associates.
Toggle Summary Premier Orthopaedics selects Allscripts to provide connected health IT platform
Orthopaedic group signs strategic agreement to deploy Allscripts Professional EHR™, Allscripts® Practice Management, FollowMyHealth® and full Payerpath® suite of solutions CHICAGO , Jan. 15, 2019 (GLOBE NEWSWIRE) -- Premier Orthopaedics has selected Allscripts (NASDAQ: MDRX) as its strategic
Toggle Summary Allscripts Joins with Microsoft to Explore Technology for Clinical Research
A new operating model to enable research as a natural output of clinical practice, through integration with point-of-care technology platforms and workflows CHICAGO , Jan. 07, 2019 (GLOBE NEWSWIRE) -- Today, Allscripts (NASDAQ:MDRX), a global leader in health care information technology, announced
Toggle Summary Allscripts to present at the J.P. Morgan 2019 Healthcare Conference
CHICAGO , Jan. 03, 2019 (GLOBE NEWSWIRE) -- Allscripts (NASDAQ: MDRX) today announced that certain members of its management team will present at the J.P. Morgan 2019 Healthcare Conference in San Francisco, CA on Monday, January 7 th at 4:00 p.m. PT .
Toggle Summary Allscripts closes previously announced sale of its interests in Netsmart
CHICAGO , Jan. 02, 2019 (GLOBE NEWSWIRE) -- Allscripts (NASDAQ: MDRX) closed the previously announced sale of its interests in Netsmart Technologies, Inc. on December 31, 2018 . Additional pro forma financial details relating to the transaction described in this press release will be provided in a
Toggle Summary Allscripts to sell its interests in Netsmart
CHICAGO , Dec. 10, 2018 (GLOBE NEWSWIRE) -- Allscripts (NASDAQ: MDRX), a global leader in healthcare information technology, today announced that it has signed a definitive agreement to sell its interests in Netsmart Technologies, Inc. (“Netsmart”). In March 2016 , Allscripts contributed its
Toggle Summary Allscripts to present at the Citi 2018 Global Healthcare Conference
CHICAGO , Dec. 04, 2018 (GLOBE NEWSWIRE) -- Allscripts (NASDAQ: MDRX) today announced that certain members of its management team will present at the Citi 2018 Global Healthcare Conference in New York, NY on Thursday, December 6 th at 9:30 a.m. ET . The live webcast and replay can be accessed at
Toggle Summary American Diabetes Association Colorado appoints Chief Medical Officer of Allscripts Analytics as New Member to Community Leadership Board
DENVER and CHICAGO, Nov. 19, 2018 (GLOBE NEWSWIRE) -- The American Diabetes Association along with Allscripts Healthcare Solutions, Inc. (Nasdaq:MDRX) announced today that the American Diabetes Association Colorado has welcomed Fatima Paruk, MD, MPH, Chief Medical Officer of Allscripts Analytics,
Toggle Summary Introducing Veradigm™ Providing Next Generation Healthcare Solutions for Today’s Healthcare Challenges
Data-driven insight and solutions CHICAGO , Nov. 14, 2018 (GLOBE NEWSWIRE) -- Today, Allscripts (NASDAQ: MDRX) announced Veradigm as the new branding for Allscripts’ Payer & Life Sciences division. Veradigm is a leader in providing data-driven health insights and analytic solutions designed to